Limaprost Alfa from Japan
Limaprost alfa, a synthetic prostaglandin E1 derivative, treats peripheral vascular disease. Falls under HTS 2937.50.00.00 as modified prostaglandin with hormonal activity. Alfa-dextran complex classifies as derivative.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Dextran complex classifies with parent prostaglandin; document host-guest chemistry
• Primarily Japanese pharmaceutical; validate PMDA vs
• FDA specifications
• Vascular smooth muscle assay data confirms primary hormonal mechanism